Transgenomic Inc.
Transgenomic, Inc. (www.transgenomic.com) is a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. The Company is the global leader in cardiac genetic testing with a family of innovative products, including its flagship C-GAAP test, designed to detect gene mutations which indicate cardiac disorders, or which can lead to serious adverse events.
Reviews
- Ease of use
- After sales service
- Value for money
"This instrument does the job if you wait long enough!"
Nicholas Leaves
‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.| Status: | No. Reviews Published: |
| Member | 0 |
Reviewer | 1-4 |
| Advanced Reviewer | 5-14 |
| Expert Reviewer | 15+ |
To be seen as an authority on SelectScience, find your products to review today., MRC geneservice
Latest news
News
Transgenomic Announces Global Availability of CRC RAScan Test for Metastatic Colorectal Cancer Patients
17 May 2013
-
Transgenomic Acquires Saliva-Based Genetic Test for Prognosis of Scoliosis
25 Sep 2012
-
Transgenomic to Provide Clinical Next-Generation Sequencing Service
01 Aug 2012
-
Transgenomic Launches Breakthrough PCR Technology for Cancer Gene Testing
06 Jun 2012
-
Transgenomic, Inc. Launches Best-in-Class Next-Generation Sequencing Test for Nuclear Mitochondrial Disorders
20 Jun 2011
